SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 307 filers reported holding SEATTLE GENETICS INC in Q4 2018. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,124,261,000 | +16.9% | 5,745,112 | +1.5% | 0.23% | +8.9% |
Q2 2020 | $961,522,000 | +3.3% | 5,658,675 | -29.8% | 0.21% | -13.0% |
Q1 2020 | $930,428,000 | -21.0% | 8,064,014 | -21.8% | 0.25% | -0.4% |
Q4 2019 | $1,177,717,000 | -13.1% | 10,307,338 | -35.1% | 0.25% | -19.3% |
Q3 2019 | $1,355,696,000 | +36.2% | 15,874,659 | +10.4% | 0.31% | +39.1% |
Q2 2019 | $995,101,000 | -7.8% | 14,377,983 | -2.4% | 0.22% | -9.8% |
Q1 2019 | $1,078,703,000 | +25.8% | 14,728,336 | -2.7% | 0.24% | +13.5% |
Q4 2018 | $857,774,000 | -1.7% | 15,138,967 | +33.7% | 0.22% | +16.8% |
Q3 2018 | $873,051,000 | +26.3% | 11,320,692 | +8.8% | 0.18% | +19.5% |
Q2 2018 | $691,016,000 | +33.4% | 10,408,424 | +5.2% | 0.15% | +31.6% |
Q1 2018 | $518,077,000 | +8313.1% | 9,898,292 | +8499.5% | 0.12% | +11600.0% |
Q4 2017 | $6,158,000 | -1.8% | 115,103 | -0.1% | 0.00% | 0.0% |
Q3 2017 | $6,271,000 | +14.6% | 115,263 | +9.0% | 0.00% | 0.0% |
Q2 2017 | $5,470,000 | +5.5% | 105,718 | +28.2% | 0.00% | 0.0% |
Q1 2017 | $5,184,000 | +85.2% | 82,463 | +55.5% | 0.00% | 0.0% |
Q4 2016 | $2,799,000 | -11.7% | 53,043 | -9.6% | 0.00% | 0.0% |
Q3 2016 | $3,171,000 | +32.7% | 58,703 | -0.8% | 0.00% | 0.0% |
Q2 2016 | $2,390,000 | +14.4% | 59,150 | -0.7% | 0.00% | 0.0% |
Q1 2016 | $2,090,000 | -94.0% | 59,553 | -92.4% | 0.00% | -88.9% |
Q4 2015 | $35,061,000 | -2.7% | 781,199 | -16.4% | 0.01% | -10.0% |
Q3 2015 | $36,039,000 | -14.0% | 934,572 | +8.0% | 0.01% | -9.1% |
Q2 2015 | $41,897,000 | +81.8% | 865,627 | +32.8% | 0.01% | +83.3% |
Q1 2015 | $23,045,000 | +17.7% | 651,898 | +6.9% | 0.01% | +20.0% |
Q4 2014 | $19,585,000 | -80.2% | 609,562 | -77.0% | 0.01% | -81.5% |
Q3 2014 | $98,741,000 | +8.4% | 2,655,747 | +11.5% | 0.03% | +8.0% |
Q2 2014 | $91,114,000 | -32.3% | 2,382,028 | -19.4% | 0.02% | -32.4% |
Q1 2014 | $134,565,000 | +12.9% | 2,953,577 | -1.1% | 0.04% | +8.8% |
Q4 2013 | $119,157,000 | -32.8% | 2,987,124 | -26.1% | 0.03% | -38.2% |
Q3 2013 | $177,221,000 | +34.6% | 4,043,379 | -3.4% | 0.06% | +27.9% |
Q2 2013 | $131,692,000 | – | 4,186,002 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parametrica Management Ltd | 3,581 | $248,000 | 42.18% |
Baker Brothers Advisors | 50,057,277 | $3,464,464,000 | 23.54% |
Lagoda Investment Management, L.P. | 76,073 | $5,265,000 | 6.10% |
Matrix Capital Management Company, LP | 3,141,852 | $217,448,000 | 4.02% |
DOMINI IMPACT INVESTMENTS LLC | 3,111 | $215,000 | 2.98% |
Opus Point Partners Management, LLC | 17,901 | $1,239,000 | 1.83% |
EMORY UNIVERSITY | 33,593 | $2,325,000 | 1.64% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,215,000 | 1.56% |
Capital International Sarl | 130,400 | $9,025,000 | 1.26% |
CAPITAL GUARDIAN TRUST CO | 1,303,961 | $90,147,000 | 1.21% |